期刊文献+

异舒吉和酚妥拉明在高血压急症中的降压效果观察 被引量:2

下载PDF
导出
摘要 目的:观察异舒吉和酚妥拉明在高血压急症中的短期降压效果。方法:将60例高血压急症患者随机分为两组,治疗组30例,应用异舒吉20mg加入生理盐水50mL中,以1~15mg/h的速度降压,对照组30例,应用酚妥拉明静脉3~30mg/h控制血压,观察治疗前后两组的血压变化。结果:治疗组总有效率93.3%,对照组总有效率85.7%。两组治疗总有效率差异有显著性。用药5min后,治疗组收缩压与对照组收缩压相比差异有显著性(P<0.05);用药30min和60min时,治疗组舒张压和对照组相比差异有显著性(P<0.05)。结论:异舒吉降压起效迅速,疗效明确。
作者 陈海襄
出处 《实用医学杂志》 CAS 2008年第20期3552-3553,共2页 The Journal of Practical Medicine
  • 相关文献

参考文献3

共引文献1536

同被引文献63

  • 1刘甲兴,芮磊.亚宁定与酚妥拉明治疗高血压急症的降压疗效比较[J].海南医学,2005,16(8):69-70. 被引量:1
  • 2杨晓晖,张力,吴桂芝,刘翠丽,杨乐.消渴丸的不良反应与合理应用[J].中国药物警戒,2006,3(2):76-80. 被引量:11
  • 3陆德澄,侯建民,汤永祥,芮涛,慈书平,陈志梅.静脉注射卡托普利和酚妥拉明治疗重症高血压病的比较[J].新药与临床,1996,15(6):328-330. 被引量:5
  • 4WHO. The selection of essential drugs : report of a WHO expert committee (WHO Technical Report Series 615) [M]. Geneva: World Health Organization, 1977 : 28~33.
  • 5WHO. The use of essential drugs : second report of the WHO expert committee (WHO Technical Report Series 722) [M]. Geneva: World Health Organization, 1985:7~8.
  • 6WHO. The use of essential drugs :ninth report of the WHO expert committee (WHO Technical Report Series 895) [M]. Geneva. World Health Organization, 2000 : 4~ 5.
  • 7WHO. The selection and use of essential drugs, report of the WHO expert committee ( WHO Technical Report Series 914) [M]. Geneva: World Health Organization, 2002 : 5 ~ 7.
  • 8Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [EB/OL]. www. cochrane-handbook.org. 2010-03-20.
  • 9Faunce TA. Toward a treaty on safety and cost(effectiveness of pharmaceuticals and medical devices: enhancing an endangered global public good[J]. Globalization and Health, 2006, 2 : 5.
  • 10Berger ML, Teutsch S. Cost-effectiveness analysis: from science to application[J]. Medical Care, 2005, 43 (7 suppl) : 49.

引证文献2

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部